Las Vegas, NV -- (SBWIRE) -- 09/30/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Nuverra Environmental Solutions Inc (NYSE:NES), Stillwater Mining Company (NYSE:SWC), New Residential Investment Corp (NYSE:NRZ), The Medicines Company (NASDAQ:MDCO)
Nuverra Environmental Solutions Inc (NYSE:NES) managed to keep its gain at 1.30% on below -normal volume of 1.47M shares. The stock settled at $2.34 after floating in a range of $2.28/ to $2.35. Its latest price has reached market capitalization of $608.26 million. Its 52-week range has been $2.06 to $4.45. Nuverra Environmental Solutions, Inc., an environmental solutions company, provides full-cycle environmental solutions to customers in energy and industrial end-markets in the United States.
For How Long NES will fight for Profitability? Read This Trend Analysis report
Stillwater Mining Company (NYSE:SWC) traded up on a volume of 1.46 million, higher than its standard daily volume. Shares have gained 0.82% to $11.06. Over the last twelve months, the stock has lost-6.19% and faced a worst price of $9.78. Stillwater Mining Company engages in developing, extracting, processing, smelting, refining, and marketing palladium, platinum, and associated metals (PGMs). It also explores for nickel, copper, gold, and silver ores.
For How Long SWC’s Gloss will Attract Investors? Find out via this report
New Residential Investment Corp (NYSE:NRZ) settled 0.60% higher at $6.71 on below -normal volume of 1.46M shares during the last trading day. The stock has its 12-month high at $7.29 and 52-week low price was $5.85. It traded in a range of $6.60 to $6.74 during the last trading day. New Residential Investment Corp., a real estate investment trust, focuses on investing in residential mortgage related assets.
Why Should Investors Buy NRZ After the Recent Fall? Just Go Here and Find Out
In the last trading session, The Medicines Company (NASDAQ:MDCO) was up on high volume, trading at a volume of 1.45M shares versus its average daily volume of 856,850.00 shares. At $34, the stock has attained market capitalization of $2.12 billion. The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide.
Will MDCO Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)